» Articles » PMID: 12682060

Substrate Recognition by Nucleotide Sugar Transporters: Further Characterization of Substrate Recognition Regions by Analyses of UDP-galactose/CMP-sialic Acid Transporter Chimeras and Biochemical Analysis of the Substrate Specificity of Parental And...

Overview
Journal J Biol Chem
Specialty Biochemistry
Date 2003 Apr 19
PMID 12682060
Citations 20
Authors
Affiliations
Soon will be listed here.
Abstract

Human UDP-Gal transporter 1 (hUGT1) and the human CMP-Sia transporter (hCST) are similar in structure, with amino acid sequences that are 43% identical, but they have quite distinct transport substrates. To define their substrate recognition regions, we constructed various chimeras between the two transporters and demonstrated that distinct submolecular regions of the transporter molecules are involved in the specific recognition of UDP-Gal and CMP-Sia (Aoki, K., Ishida, N., and Kawakita, M. (2001) J. Biol. Chem. 276, 21555-21561). In a further attempt to define the minimum submolecular regions required for the recognition of specific substrates, we found that substitution of helix 7 of hCST into the corresponding part of hUGT1 was necessary and sufficient for a chimera to show CST activity. Additional replacement of helix 2 or 3 of hUGT1 with the corresponding hCST sequence markedly increased the efficiency of CMP-Sia transport. For UGT activity, helices 1 and 8 of hUGT1 were necessary (but not sufficient), and helices 9 and 10 or helices 2, 3, and 7 derived from hUGT1 were also required to render the chimera competent for UDP-Gal transport. The in vitro analyses of a chimera with dual specificity indicated that it transported both UMP and CMP and mediated exchange reactions between these nucleotides and nucleotide sugars that are recognized specifically by either of the parental transporters.

Citing Articles

Somatic variants in SLC35A2 leading to defects in N-glycosylation in mild malformation of cortical development with oligodendroglial hyperplasia in epilepsy (MOGHE).

Liu X, Tang Q, Xia X, Liu Q, Liu J, Jin Y Acta Neuropathol. 2025; 149(1):13.

PMID: 39900685 DOI: 10.1007/s00401-025-02850-1.


Structure-Function Relationships of the CMP-Sialic Acid Transporter through Analysis of a Pathogenic Variant in an Alternatively Spliced Functional Isoform.

Velazquez-Dodge B, Ramirez-Martinez M, Pastor N, Martinez-Duncker I, Perez-Cervera Y, Mora-Montes H ACS Omega. 2025; 9(51):50622-50633.

PMID: 39741807 PMC: 11683650. DOI: 10.1021/acsomega.4c08466.


The NMR studies of CMP inhibition of polysialylation.

Lu B, Liao S, Liu X, Liang S, Huang J, Lin M J Enzyme Inhib Med Chem. 2023; 38(1):2248411.

PMID: 37615033 PMC: 10453990. DOI: 10.1080/14756366.2023.2248411.


Measurement of CMP-Sialic Acid Transporter Activity in Reconstituted Proteoliposomes.

Cahill J, Ahuja S, Whorton M Bio Protoc. 2021; 10(6):e3551.

PMID: 33659525 PMC: 7842783. DOI: 10.21769/BioProtoc.3551.


Stable Protein Sialylation in Physcomitrella.

Bohlender L, Parsons J, Hoernstein S, Rempfer C, Ruiz-Molina N, Lorenz T Front Plant Sci. 2021; 11:610032.

PMID: 33391325 PMC: 7775405. DOI: 10.3389/fpls.2020.610032.